Evidence map›Paper›PMID 21315459›Full record

ReviewTrends in neurosciences2011

Development and cancer of the cerebellum.

Mary E Hatten, Martine F Roussel

Abstract readReview
In one paragraph

Review in Trends in neurosciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. An EED/PRC2-H19 Loop Regulates Cerebellar Development.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Human organoids in basic research and clinical applications.Signal transduction and targeted therapy · 2022
    Review
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mary E HattenLaboratory of Developmental Neurobiology, The Rockefeller University, New York, NY 10065, USA. hatten@rockefeller.edu
Martine F Roussel

Funding

Role of mPar6 Polarity in CNS Neuronal MigrationR01NS051778 · NINDS · ROCKEFELLER UNIVERSITY · PI HATTEN, MARY ELIZABETH · 2006 to 2015
$3.7M
GENETIC BASIS OF BRAIN DEVELOPMENT &DYSFUNCTIONR13NS039808 · NINDS · KEYSTONE SYMPOSIA · PI HATTEN, MARY ELIZABETH · 2000 to 2000
$20k
NCI NIH HHS CA-096732NINDS NIH HHS R01 NS051778NINDS NIH HHS R01-NS051778NINDS NIH HHS R13 NS039808
6 · The paper itself

Abstract

Medulloblastoma (MB) is the most common malignant pediatric brain tumor and is thought to arise from genetic anomalies in developmental pathways required for the normal maturation of the cerebellar cortex, notably developmental pathways for granule cell progenitor (GCP) neurogenesis. Over the past decade, a wide range of studies have identified genes and their regulators within signaling pathways, as well as noncoding RNAs, that have crucial roles in both normal cerebellar development and pathogenesis. These include the Notch, Wnt/β-catenin, bone morphogenic proteins (Bmp) and Sonic Hedgehog (Shh) pathways. In this review, we highlight the function of these pathways in the growth of the cerebellum and the formation of MB. A better understanding of the developmental origins of these tumors will have significant implications for enhancing the treatment of this important childhood cancer.

Indexed as

AnimalsCerebellar NeoplasmsChildDisease Models, AnimalHumansMedulloblastoma

Identifiers

PMID21315459
PMCPMC3051031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.